Relay Therapeutics RLAY Growth Metrics (2019-2026)

NASDAQ RLAY
$18.40 -0.05 (-0.27%)
As of: Oct 21, 2026 · 3:47 PM EDT
Reported Financials

Relay Therapeutics Quarterly Growth Metrics

Periods 28 quarters
Latest Jun 2026

Relay Therapeutics reported revenue growth of -48.30% and asset growth of 32.74% for the quarter ended Jun 2026. These growth metrics cover 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
-10.65%26.08%23.15%24.50%74.02%9.06%9.23%8.16%-22.40%-23.26%-18.90%-19.69%2.55%3.24%-5.00%-5.66%-27.97%-28.69%-12.48%32.74%
Assets Growth (3y)
40.91%40.34%6.46%1.81%2.94%2.64%11.47%-4.76%-5.59%-6.42%-16.93%-17.33%-12.31%0.19%
Assets Growth (5y)
17.26%15.93%-2.27%-4.93%-1.93%6.25%
Assets (QoQ)
-5.99%50.15%-5.81%-6.36%31.40%-5.90%-5.66%-7.28%-5.72%-6.94%-0.30%-8.19%20.40%-6.32%-8.26%-8.82%-8.07%-7.26%12.60%38.28%
Capital Expenditures Growth (1y)Capex Growth (1y)
300.92%1,275.00%486.97%389.97%20.68%163.18%-31.46%-19.06%-71.84%-94.91%-7.05%-99.27%-61.53%-78.43%136.36%-100.44%
Capital Expenditures Growth (3y)Capex Growth (3y)
-4.26%57.04%23.36%53.69%10.86%22.62%55.22%-69.27%-49.24%-48.39%-75.90%-26.00%-92.44%
Capital Expenditures Growth (5y)Capex Growth (5y)
-37.54%-17.75%-42.51%-14.90%-56.47%
Capital Expenditures (QoQ)Capex (QoQ)
358.05%-49.31%217.50%-33.54%12.82%10.55%-17.31%-21.51%-60.75%-80.00%1,408.47%-99.38%1,963.64%-93.23%-103.85%200.00%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-59.13%-37.42%-54.54%-58.57%55.16%-45.81%35.02%35.43%-57.33%-5.31%-5.21%-8.07%0.68%-13.53%-38.81%-15.05%-39.90%-32.40%118.71%6.36%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
39.89%130.27%53.52%31.86%2.11%-35.32%-31.52%-16.52%-19.81%-12.64%-23.73%-7.83%1.88%-36.32%-17.89%8.25%-6.00%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
27.79%39.30%24.26%5.87%-3.63%-30.37%-28.44%-4.88%-14.16%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-12.12%22.56%-57.36%-9.80%229.18%-57.20%6.25%-9.53%3.72%-5.02%6.35%-12.26%13.59%-18.42%-24.74%21.81%-19.64%-8.24%143.51%-40.76%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
3.56%-283.07%51.89%66.44%30.79%49.81%167.01%18.18%162.50%140.61%-86.02%-11.17%-276.78%-51.41%303.24%64.97%131.49%22.29%-22.52%-569.79%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
56.62%-82.65%14.35%-16.36%52.62%40.63%26.93%20.45%-100.58%28.04%33.47%20.09%13.48%30.87%-24.12%-107.12%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
-81.75%-4.18%-3.36%-3.03%14.63%19.77%16.44%-73.10%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
-20.26%-1,508.31%61.61%138.61%-37.34%-640.46%151.26%-31.92%39.18%-16.38%-82.35%332.53%-376.97%122.98%46.44%76.96%-47.14%-10.73%-7.22%-1,172.99%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-121.30%-12.57%-205.43%-102.89%-24.34%-43.75%-36.52%-20.16%-13.99%-56.25%25.04%4.03%0.42%35.12%-45.48%16.06%17.27%22.47%30.18%2.08%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-55.76%-35.86%-44.32%-48.75%-46.38%-36.24%-45.48%-32.75%-12.17%-13.38%-14.19%1.08%2.07%7.71%8.69%7.61%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-33.81%-20.52%-26.80%-21.53%-20.91%-4.93%-25.36%-13.97%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-89.05%25.36%-23.84%-16.11%-15.85%13.71%-17.61%-2.19%-9.91%-18.29%43.58%-30.82%-14.05%22.93%-26.51%24.52%-12.41%27.78%-13.92%-5.86%
EBITDA Margin Growth (1y)
-1.04M0.18M-1.57M-1.66M-2.95M-6.69M2.44M4.33M-0.02M-0.15M-1.46M
EBITDA Margin Growth (3y)
0.35M1.36M0.99M2.75M4.16M6.21M
EBITDA Margin Growth (5y)
0.18M-0.30M
EBITDA Margin (QoQ)
1.38M-0.28M-0.30M-0.63M-0.36M-0.37M-1.59M-4.38M8.77M-1.01M-0.17M-2.32M
EBIT Growth (1y)
-66.61%-293.56%-47.91%59.80%-40.83%-7.57%-61.31%-36.29%14.34%-26.55%10.69%4.99%-30.98%7.83%6.08%23.73%16.58%28.65%7.40%-18.19%
EBIT Growth (3y)
-57.53%-57.68%-41.28%-56.38%-56.40%-26.20%-66.73%-28.68%19.56%-16.47%-7.86%-10.61%0.41%2.18%5.94%8.08%5.04%
EBIT Growth (5y)
-38.31%-34.48%-26.89%-26.25%-22.62%-17.04%-30.14%-13.13%14.05%
EBIT Margin Growth (1y)
-1.05M0.16M-1.58M-1.69M-2.98M-6.78M2.47M4.39M-0.02M-0.15M-1.46M
EBIT Margin Growth (3y)
0.36M1.39M1.00M2.79M4.21M6.32M
EBIT Margin Growth (5y)
0.18M-0.30M
EBIT Margin (QoQ)
1.38M-0.28M-0.30M-0.63M-0.37M-0.38M-1.60M-4.43M8.88M-1.02M-0.18M-2.33M
EBIT (QoQ)
68.49%-11.04%7.39%-24.06%-10.39%15.18%-38.88%-4.82%30.62%-25.31%1.99%-11.50%4.36%11.82%0.13%9.45%-4.61%24.58%-29.62%-15.57%
EBT Growth (1y)
-68.64%-291.18%-47.05%60.29%-38.38%-0.03%-51.93%-28.23%21.91%-23.74%13.61%6.38%-34.02%8.97%5.35%24.37%16.02%27.74%4.95%-20.03%
EBT Growth (3y)
-63.61%-62.35%-41.31%-55.87%-54.47%-22.14%-63.45%-24.51%21.88%-13.14%-4.06%-7.50%3.16%4.21%6.63%8.06%5.28%
EBT Growth (5y)
-39.37%-34.96%-26.02%-25.36%-21.15%-15.45%-28.89%-11.67%15.42%
EBT Margin Growth (1y)
-1.04M0.19M-1.53M-1.48M-2.69M-6.17M2.42M4.09M-0.02M-0.14M-1.36M
EBT Margin Growth (3y)
0.36M1.38M1.07M2.59M3.93M5.88M
EBT Margin Growth (5y)
0.20M-0.10M
EBT Margin (QoQ)
1.38M-0.28M-0.29M-0.62M-0.34M-0.22M-1.50M-4.11M8.25M-0.93M-0.17M-2.15M
EBT (QoQ)
68.55%-10.89%8.05%-23.83%-9.60%19.84%-39.65%-4.52%33.26%-27.02%2.50%-13.26%4.46%13.72%-1.38%9.49%-6.08%25.77%-33.35%-14.30%
EPS (Basic) Growth (1y)
78.14%-185.66%-22.51%66.40%-15.64%15.17%-35.58%-14.54%29.14%-13.25%19.92%14.24%-16.83%21.90%26.79%40.81%31.54%39.87%10.51%-0.42%
EPS (Basic) Growth (3y)
48.85%48.42%55.73%49.39%48.89%43.63%-41.33%-9.97%30.89%1.44%9.13%7.37%16.54%17.25%18.98%19.35%20.12%
EPS (Basic) Growth (5y)
33.36%35.28%40.15%40.27%41.62%32.20%-19.00%2.72%27.80%
EPS (Basic) (QoQ)
68.80%-8.04%19.19%-23.36%-7.38%20.75%-29.15%-4.22%33.57%-26.66%8.68%-11.61%9.50%15.33%14.40%9.76%-4.68%25.63%-27.39%-1.26%
EPS (Diluted) Growth (1y)
-185.66%42.11%84.42%-15.64%15.17%-35.58%-14.54%29.14%-13.25%19.92%14.24%-16.83%21.90%26.79%40.81%31.54%39.87%10.51%-0.42%
EPS (Diluted) Growth (3y)
-41.33%14.34%46.52%1.44%9.13%7.37%16.54%17.25%18.98%19.35%20.12%
EPS (Diluted) Growth (5y)
-19.00%16.26%38.09%
EPS (Diluted) (QoQ)
85.54%-8.04%19.19%-23.36%-7.38%20.75%-29.15%-4.22%33.57%-26.66%8.68%-11.61%9.50%15.33%14.40%9.76%-4.68%25.63%-27.39%-1.26%
FCF Margin Growth (1y)
-1.73M-1.28M-1.16M-1.63M-1.81M-4.28M1.95M3.00M-0.04M-0.07M-0.73M
FCF Margin Growth (3y)
-0.54M1.14M0.80M2.28M2.88M4.35M
FCF Margin Growth (5y)
-0.66M-1.21M
FCF Margin (QoQ)
-0.49M0.11M-0.52M-0.37M-0.37M-0.36M-0.71M-2.84M5.86M-0.72M-0.11M-1.38M
Free Cash Flow Growth (1y)FCF Growth (1y)
-124.48%-14.86%-212.57%-106.70%-24.22%-46.34%-32.86%-18.92%-11.35%-50.36%24.54%6.08%0.89%35.20%-41.25%16.03%17.52%22.47%30.55%2.13%
Free Cash Flow Growth (3y)FCF Growth (3y)
-50.82%-36.49%-43.52%-48.85%-45.89%-36.21%-46.26%-32.17%-11.09%-12.55%-12.30%2.12%3.08%8.93%9.54%8.27%
Free Cash Flow Growth (5y)FCF Growth (5y)
-30.51%-19.89%-25.80%-21.07%-20.48%-4.89%-25.45%-13.67%
Free Cash Flow (QoQ)FCF (QoQ)
-92.63%26.12%-28.04%-13.44%-15.76%12.96%-16.25%-1.53%-8.39%-17.53%41.66%-26.37%-14.38%23.16%-27.18%24.88%-12.36%27.77%-13.92%-5.86%
Net Cash Flow Growth (1y)NCF Growth (1y)
-107.46%146.19%13.11%-1,131.23%883.58%-493.42%105.90%-30.19%-97.80%96.26%-3.70%-22.94%225.18%-269.73%-436.75%206.10%-226.82%69.83%492.16%-519.41%
Net Cash Flow Growth (3y)NCF Growth (3y)
196.04%-160.68%-30.62%-30.62%-76.58%59.18%27.02%-170.11%36.80%-36.52%42.38%54.64%-27.87%65.31%133.42%-76.21%
Net Cash Flow Growth (5y)NCF Growth (5y)
29.99%-33.08%-25.26%-21.50%-15.47%40.30%21.54%-144.68%
Net Cash Flow (QoQ)NCF (QoQ)
-3,213.35%263.63%-411.63%92.71%2,208.69%-182.16%104.67%-260.78%135.59%-239.92%220.26%-305.27%194.15%-259.09%-9.53%164.68%-212.53%62.16%1,523.84%-169.17%
Net Income Growth (1y)
-68.62%-291.22%-47.08%60.30%-38.37%-0.07%-51.89%-28.28%21.91%-23.69%13.64%6.39%-34.03%8.97%5.31%23.68%15.84%27.78%4.90%-18.94%
Net Income Growth (3y)
-63.60%-62.34%-41.33%-55.87%-54.47%-22.14%-63.45%-24.49%21.88%-13.14%-4.06%-7.49%2.87%4.14%6.66%8.04%5.28%
Net Income Growth (5y)
-39.37%-34.97%-26.02%-25.37%-21.37%-15.50%-28.88%-11.68%15.42%
Net Income (QoQ)
68.55%-10.89%8.02%-23.76%-9.62%19.80%-39.61%-4.53%33.27%-27.02%2.52%-13.30%4.45%13.73%-1.40%8.68%-5.36%25.97%-33.52%-14.21%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
71.56%-291.22%-47.08%60.30%-38.37%-0.07%-51.89%-28.28%21.91%-23.69%13.64%6.39%-34.03%8.97%5.31%23.68%15.84%27.78%4.90%-18.94%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-63.60%-62.34%-41.33%-55.87%-54.47%32.51%-63.45%-24.49%21.88%-13.14%-4.06%-7.49%2.87%4.14%6.66%8.04%5.28%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-39.37%-34.97%-26.02%-25.37%-21.37%19.09%-28.88%-11.68%15.42%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
68.55%-10.89%8.02%-23.76%-9.62%19.80%-39.61%-4.53%33.27%-27.02%2.52%-13.30%4.45%13.73%-1.40%8.68%-5.36%25.97%-33.52%-14.21%
Net Margin Growth (1y)
-1.04M0.19M-1.53M-1.48M-2.69M-6.17M2.42M4.09M-0.02M-0.14M-1.35M
Net Margin Growth (3y)
0.36M1.38M1.06M2.59M3.93M5.89M
Net Margin Growth (5y)
0.20M-0.10M
Net Margin (QoQ)
1.38M-0.28M-0.29M-0.62M-0.34M-0.22M-1.50M-4.11M8.25M-0.94M-0.17M-2.15M
Operating Income Growth (1y)Op. Inc Growth (1y)
-66.61%-293.56%-47.91%59.80%-40.83%-7.57%-61.31%-36.29%14.34%-26.55%10.69%4.99%-30.98%7.83%6.08%23.73%16.58%28.65%7.40%-18.19%
Operating Income Growth (3y)Op. Inc Growth (3y)
-57.53%-57.68%-41.28%-56.38%-56.40%-26.20%-66.73%-28.68%19.56%-16.47%-7.86%-10.61%0.41%2.18%5.94%8.08%5.04%
Operating Income Growth (5y)Op. Inc Growth (5y)
-38.31%-34.48%-26.89%-26.25%-22.62%-17.04%-30.14%-13.13%14.05%
Operating Income (QoQ)Op. Inc (QoQ)
68.49%-11.04%7.39%-24.06%-10.39%15.18%-38.88%-4.82%30.62%-25.31%1.99%-11.50%4.36%11.82%0.13%9.45%-4.61%24.58%-29.62%-15.57%
Operating Margin Growth (1y)
-1.05M0.16M-1.58M-1.69M-2.98M-6.78M2.47M4.39M-0.02M-0.15M-1.46M
Operating Margin Growth (3y)
0.36M1.39M1.00M2.79M4.21M6.32M
Operating Margin Growth (5y)
0.18M-0.30M
Operating Margin (QoQ)
1.38M-0.28M-0.30M-0.63M-0.37M-0.38M-1.60M-4.43M8.88M-1.02M-0.18M-2.33M
Profit After Tax Growth (1y)PAT Growth (1y)
-68.64%-291.18%-47.05%60.29%-38.38%-0.03%-51.93%-28.23%21.91%-23.74%13.61%6.38%-34.02%8.97%5.35%24.37%16.02%27.74%4.95%-20.03%
Profit After Tax Growth (3y)PAT Growth (3y)
-63.61%-62.35%-41.31%-55.87%-54.47%-22.14%-63.45%-24.51%21.88%-13.14%-4.06%-7.50%3.16%4.21%6.63%8.06%5.28%
Profit After Tax Growth (5y)PAT Growth (5y)
-39.37%-34.96%-26.02%-25.36%-21.15%-15.45%-28.89%-11.67%15.42%
Profit After Tax (QoQ)PAT (QoQ)
68.55%-10.89%8.05%-23.83%-9.60%19.84%-39.65%-4.52%33.26%-27.02%2.50%-13.26%4.46%13.72%-1.38%9.49%-6.08%25.77%-33.35%-14.30%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
-5.17%4.69%50.74%36.03%82.56%77.81%34.21%31.69%-6.05%-6.30%-17.36%-28.93%-32.62%-45.78%-47.87%-58.55%-67.28%-70.80%-76.26%-75.09%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
12.86%16.71%17.60%20.37%18.68%8.38%4.94%-3.33%-16.69%-27.07%-40.83%-47.06%-53.24%-58.14%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
-6.09%-14.08%-18.55%-22.69%-27.03%-33.36%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-4.88%4.87%36.08%0.20%27.66%2.14%2.72%-1.68%-8.92%1.87%-9.41%-15.44%-13.65%-18.02%-12.91%-32.77%-31.84%-26.83%-29.20%-29.46%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
0.00M0.00M0.00M277.00945.000.00M899.00-540.00-665.000.00M-886.00-556.00-567.00156.00-85.00-68.00-188.00-521.00-126.00639.00
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.00M0.00M0.00M-819.00-287.00582.00-72.000.00M0.00M0.00M0.00M15.00
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.00M0.00M0.00M-248.00
Return on Assets [ROA] (QoQ)ROA (QoQ)
-586.00-564.00413.000.00M82.00262.00-459.00-425.00-43.00-418.000.00-95.00-54.00305.00-241.00-78.00-175.00-27.00154.00687.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.00M0.00M0.00M237.00871.000.00M724.00-868.00-930.000.00M0.00M-741.00-719.0031.00-101.00-5.00-185.00-500.00-103.00723.00
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.00M0.00M0.00M0.00M-778.0089.00-490.000.00M0.00M0.00M0.00M-23.00
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.00M0.00M-654.00
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-631.00-528.00364.000.00M3.00276.00-588.00-559.00-59.00-411.00-83.00-188.00-36.00338.00-215.00-92.00-216.0023.00182.00734.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
182.000.00M0.00M204.000.00M0.00M891.00-773.00-839.000.00M-875.00-456.00-437.00291.00-53.0039.00-121.00-516.00-49.00753.00
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
468.000.00M0.00M0.00M-150.00776.00-37.000.00M0.00M0.00M-977.00336.00
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
-89.000.00M0.00M-233.00
Return on Equity [ROE] (QoQ)ROE (QoQ)
-892.00-564.00543.000.00M30.00285.00-540.00-547.00-37.00-365.0074.00-128.00-17.00362.00-270.00-36.00-178.00-32.00197.00765.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-1.05M0.16M-1.58M-1.69M-2.98M-6.78M2.47M2.73M4.39M8.81M-0.35M-0.23M-0.02M-1.03M-0.01M0.29M-0.15M-1.46M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
0.36M2.19M0.54M0.82M1.39M1.00M2.11M2.79M4.21M6.32M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
0.18M-0.30M
Return on Sales [ROS] (QoQ)ROS (QoQ)
1.38M-0.28M-0.30M-0.63M-0.37M-0.38M-1.60M-4.43M8.88M-0.12M0.06M-0.01M-0.28M0.01M0.26M-1.02M0.74M0.30M-0.18M-2.33M
Revenue Growth (1y)
-55.99%-56.75%-48.35%-55.38%-46.06%-67.40%7,226.16%-100.40%4,327.88%-23.26%-60.93%-48.30%
Revenue Growth (3y)
119.06%163.65%22.87%202.45%136.78%43.28%
Revenue Growth (5y)
25.80%-16.14%
Revenue (QoQ)
-21.09%-14.86%-26.10%-12.89%-5.75%-26.45%-10.67%-47.35%21,078.15%-100.00%1,000,800.00%-91.18%-57.14%-88.33%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
4.10%-29.74%39.13%-6.19%10.48%35.22%59.93%54.56%59.16%39.44%26.35%14.61%2.97%-8.47%-28.92%-45.96%-30.94%-25.90%-45.47%-36.70%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
122.35%119.53%145.46%79.74%22.33%9.83%41.14%18.45%21.88%19.95%12.83%-1.44%4.21%-1.84%-21.18%-26.81%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
78.29%68.30%67.75%29.17%5.41%-2.12%1.73%-10.68%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
-23.09%-17.72%31.68%12.58%-9.43%0.71%55.74%8.80%-6.73%-11.76%41.11%-1.31%-16.20%-21.57%9.58%-24.97%7.08%-15.84%-19.36%-12.89%

Relay Therapeutics Growth Metrics API

Pull Relay Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RLAY&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY